Pas de connexion internet — affichage de la version enregistrée de la page.

Fennec Pharmaceut…

USUSD
← Vers le Screener
US:FENCTO:FRX

Fennec Pharmaceuticals Inc (US:FENC) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
fennecpharma.com
Relations avec les Investisseurs
investors.fennecpharma.com/
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège Social
RESEARCH TRIANGLE PARK, United States
PDG
Jeffrey S. Hackman
Employés
35
Actions en Circulation
35.07 M au 2026-08-11
Flottant
19.88 M
Capitalisation Boursière
375.57 M USD
Initiés
14.13%
Investisseurs Institutionnels
54.24%
Secteur d'Activité (SIC)
Biological Products, (No Diagnostic Substances)
P/E
perte
FCF
3.92 M USD
Dette
19.4 M USD
trésorerie nette
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksFENC principaleUSD10.72 +0.09%actions ordinaires
TO Toronto Stock ExchangeFRX secondaireCAD14.47 -0.14%actions ordinaires

Cours sur 3 Mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
Rosalind Advisors, Inc.9.07%3.19 M2026-06-30
AIGH Capital Management…7.07%2.49 M2026-06-30
Solas Capital Management…5.38%1.89 M2026-06-30
Blackrock Inc.4.92%1.73 M2026-06-30
AWM Investment Company,…3.3%1.16 M2026-06-30
Vanguard Capital Managem…2.39%839 3062026-06-30
VANGUARD INDEX FUNDS-Van…2.32%815 1922026-06-30
iShares Trust-iShares Ru…2.11%742 1942026-08-31
Prospect Capital Advisor…1.42%497 8002026-06-30
State Street Corporation1.21%426 0042026-06-30
Geode Capital Management…1.15%402 5662026-06-30
Fidelity Salem Street Tr…0.9%316 4712026-07-31
iShares Trust-iShares Ru…0.78%274 7812026-08-31
ANDRADE ROBERT C (Chief…≈0.69%241 3062026-08-31
Jane Street Group, LLC0.67%233 8772026-06-30
VANGUARD SCOTTSDALE FUND…0.42%149 1562026-05-31
RAYKOV ROSTISLAV CHRISTO…≈0.35%124 4112026-09-01
Bridgeway Funds, Inc.-Ul…0.31%108 0052026-06-30
iShares Trust-iShares Mi…0.28%98 2942026-08-31
College Retirement Equit…0.24%85 1242026-06-30
SCHWAB CAPITAL TRUST-Sch…0.2%70 5042026-07-31
HACKMAN JEFFREY S (Chief…≈0.19%67 4612026-09-30
RALLIS CHRISTOPHER ANIGE…≈0.18%63 0772026-05-11
Quantitative Master Seri…0.14%50 4812026-06-30
CIOFFI CHRISTIANA MARIE…≈0.07%24 6442026-08-31
EVANS TERRY L (Officer)≈0.06%21 6872026-09-30
SAYAD PIERRE SARGIS PH.D…≈0.03%9 6872026-09-30
BRUGHERA MARCO MARIA (Di…—02026-09-15
SOUTHPOINT CAPITAL ADVIS…——2025-12-24